Mashup Score:21
PubMedTwitter Feed: Monica Gandhi MD, MPH
Mashup Score:13
Los Angeles, CA PatchLA Residents Can Get Free Uber Rides For Monkeypox Vaccination - 11 hours
Mashup Score:13
The rideshare giant is partnering with a statewide LGBTQ+ civil rights organization to provide free rides to monkeypox vaccination...
-
MONKEYPOX VACCINE: Cases coming down in US but immunity important for affected populations. California has highest number of cases (more in LA) now more than NY. Uber offering free rides for MPX vaccination in LA- please use! https://t.co/sFb9lBNqzB - view on twitter
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention...
-
Weakness in arms/legs/ "bulbar" or breathing issues. Rare (<700 cases since 2014) but serious complication rarely of enterovirus D68. ED68 like all enteroviruses more common in late summer-early fall so in season of risk. CDC reports <100 cases so far. https://t.co/YEXvCwXdyn - view on twitter
Mashup Score:6
www.pbs.orgEnding HIV in America - 1 day
Mashup Score:6
Science has made extraordinary progress against HIV. Can innovative drugs and therapies finally end...
-
ENDING AIDS IN AMERICA: PBS NOVA SPECIAL Wednesday October 5 at 9pm EDT. Written/Produced by Caleb Hellerman. Directed by Shayon Maitra. We have amazing advances in HIV treatment & prevention- can we apply them & end AIDS? Features @UCSF clinic Ward 86! https://t.co/807TS6aUUL - view on twitter
Mashup Score:150
TimeThe CDC’s Booster Recommendations May Not Provide Optimal Protection - 1 day
Mashup Score:150
The new Omicron-boosters are here but we should rethink the interval period to maximize their...
-
BOOSTERS: Yes, would wait a bit of time between infection & next booster per @NIAIDSnews. @MichaelDaignau3 & I discuss here. Thanks https://t.co/vup45Qbmma https://t.co/vup45Qbmma - view on twitter
Mashup Score:62
MedscapeCOVID-19 Vaccines Work Better Than Expected - 1 day
Mashup Score:62
COVID vaccines are said to “wane” in efficacy but that refers to only one arm of the immune...
-
COVID-19 VACCINES WORK WELL: Due to the redundancy of the immune system, even among those with different parts of the immune system compromised, and due to fact that they elicit antibodies, T and B cells. Antibodies come down with time but T/B cells endure https://t.co/YmaUhymVXl - view on twitter
Mashup Score:15
MedscapePolio Making a Comeback in the US - 1 day
Mashup Score:15
Poliovirus is spreading in the wastewater in New York City, and the United States has already seen one case of paralytic polio. We cannot...
-
POLIO AND MEASLES VACCINES WORK WELL TOO: https://t.co/j38CZqtOom - view on twitter
Mashup Score:28
National Institutes of Health (NIH)NIH launches clinical trial of three mRNA HIV vaccines - 1 day
Mashup Score:28
Phase 1 study is among first to examine mRNA technology for...
-
HIV DOESN'T YET HAVE A VACCINE: But NIH just launched 3 mRNA vaccines trials for HIV which we in the field are very excited about. mRNA vaccine and whole virus vaccine being studied for influenza; whole virus vaccines available for COVID too approved @WHO https://t.co/sVpZTdqKuW - view on twitter
Mashup Score:17
FrontiersRemembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination - 2 days
Mashup Score:17
The success of vaccines is dependent on the generation and maintenance of immunological memory. The immune system can remember previously encountered pathogens, and memory...
-
Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination- we have discussed T cells many times, but what of the memory B cells? https://t.co/1mx1qZCebu - view on twitter
Mashup Score:26
JAMA NetworkAssociation of Vaccination and Prior Infection With SARS-CoV-2 Infections and COVID-19 Outcomes - 2 days
Mashup Score:26
This study uses data from March 2020 to June 2022 to examine the association of the primary and booster COVID-19 vaccines with SARS-CoV-2 infection,...
-
Another paper today JAMA this time >10 million people in N Carolina. Vaccination + infection provides strongest protection against mild infection during Omicron; booster lasts 4-6 months; protection from severe disease much longer. Pls read editorial too https://t.co/5i4Y3lOPPR - view on twitter
The number of COVID-19 vaccine doses and severe clinical outcomes in older patients infected with a SARS-CoV-2 Omicron...
BOOSTERS: Japanese study, median age 68, 3rd dose (1st booster) improves severe disease. In US, 71% of those >65 have had 1st booster (3rd dose) - need to increase booster (now Omicron specific) rate in older people in US https://t.co/I9HYk23uUJ - view on twitter